spellspell8705 spellspell8705 13-10-2022 Medicine contestada 64.hongo, h.; kosaka, t.; suzuki, y.; oya, m. discovery of a new candidate drug to overcome cabazitaxel-resistant gene signature in castration-resistant prostate cancer by in silico screening. prostate cancer prostatic dis. 2021.